Invasive pulmonary and cerebral aspergillosis in a patient with Weil's disease

Scandinavian Journal of Infectious Diseases

Volumn 37, Issue 5, 2005, Pages 396-398

  Cocchi, Stefania ^a   Codeluppi, Mauro ^a   Guaraldi, Giovanni ^a   Squillace, Nicola ^a   Bedini, Andrea ^a   Venturelli, Claudia ^b   Esposito, Roberto ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; ANTIFUNGAL AGENT; CASPOFUNGIN; IMIPENEM; ITRACONAZOLE; PENICILLIN G; VORICONAZOLE;

ADULT; ARTICLE; ASPERGILLOSIS; ASPERGILLUS FLAVUS; BRAIN INFECTION; BRONCHOSCOPY; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; FUNGUS CULTURE; HEMOFILTRATION; HUMAN; HUMAN TISSUE; INVASIVE ASPERGILLOSIS; KIDNEY FAILURE; LEPTOSPIRA INTERROGANS; LEPTOSPIROSIS; LUNG ASPERGILLOSIS; LUNG LAVAGE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; THORAX RADIOGRAPHY;

EID: 18844428654     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.1080/00365540410021199-1     Document Type: Article

References (12)

1. Pinel C, Fricker-Hidalgo H, Lebeau B, Garban F, Hamidfar R, Ambroise-Thomas P, Grillot R. Detection of circulating Aspergillus fumigatus galactomannan: value and limits of the Platelia test for diagnosing invasive aspergillosis. J Clin Microbiol 2003;41:2184-6.
2. Ascioglu S, Rex JH, de Pauw B, Bennett JE, Bille J, Crokaert F, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and haemopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002;34:7-14.
3. Levy H, Horak DA, Tegtmeier BR, Yokota SB, Forman SJ. The value of bronchoalveolar lavage and bronchial washings in the diagnosis of invasive pulmonary aspergillosis. Respir Med 1992;86:243-8.
4. Kahn FW, Jones JM, England DM. The role of bronchoalveolar lavage in the diagnosis of invasive pulmonary aspergillosis. Am J Clin Pathol 1986;86:518-23.
5. Park GR, Drummond GB, Lamb D, Durie TB, Milne LJ, Lambie AT, Cameron EW. Disseminated aspergillosis occurring in patients with respiratory, renal, and hepatic failure. Lancet 1982;2:179-83.
6. Walsh TJ, Hamilton SR. Disseminated aspergillosis complicating hepatic failure. Arch Intern Med 1983;143:1189-91.
7. Singh N, Arnow PM, Bonham A, Dominguez E, Paterson DL, Pankey GA, et al. Invasive aspergillosis in liver transplant recipients in the 1990s. Transplantation 1997;64:716-20.
8. Manavathu EK, Ganesan LT, Cutright JL, Chandrasekar PH. In vitro antifungal activity of voriconazole in 2-drug combination with micafungin, caspofungin, and amphotericin B [abstract J-125]. In: Program and abstracts of the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy (Chicago). Washington, DC: American Society for Microbiology, 2001.
9. Kirkpatrick WR, Perea S, Coco BJ, Patterson T. Efficacy of caspofungin alone and in combination with voriconazole in a Guinea pig model of invasive aspergillosis. Antimicrob Agents Chemother 2002;46:2564-8.
10. Steinbach WJ, Stevens DA, Denning DW. Combination and sequential antifungal therapy for invasive aspergillosis: review of published in vitro and in vivo interactions and 6281 clinical cases from 1996 to 2001. Clin Infect Dis 2003; 37(Suppl 3):S188-224.
11. Thiébaut SR, Antal D, Breysse MC, Pivot C. Refractory invasive fungal infections in patients with haematological malignancies: combination of new antifungal agents (voriconazole or caspofungin) with amphotericin B. ICAAC 2002 [abstract M-859]. In: Program and abstracts of the 42st Interscience Conference on Antimicrobial Agents and Chemotherapy (San Diego). Washington, DC: American Society for Microbiology, 2002.
12. Gentina T, De Botton S, Alfandari S, Delomez J, Jaillard S, Leroy O, et al. Combination antifungals for treatment of pulmonary invasive aspergillosis refractory to amphotericin B in leukaemia patients. ICAAC 2002 [abstract M-860]. In: Program and abstracts of the 42st Interscience Conference on Antimicrobial Agents and Chemotherapy (San Diego). Washington, DC: American Society for Microbiology, 2002.